What question did this study set out to answer?

To address the challenge of subtype differentiation in primary aldosteronism for improved management and treatment.

January 10, 2026Journal of Internal MedicineOpen Access

Standard adrenal imaging misclassifies ~33% of primary aldosteronism patients, driving the need for novel diagnostics.

View Full Paper

Ask AI

Bookmark

Why the study?

Current subtype differentiation in primary aldosteronism via CT, MRI, and adrenal vein sampling has major limitations, creating a need for more accurate diagnostic approaches.

Design

Review

Key result

Adrenal imaging misclassifies over one third of patients with primary aldosteronism, highlighting the need for more accurate diagnostic techniques for subtype differentiation.

Authors

ÓRÓskar Ragnarsson CJC. Christofer Juhlin TÅTobias Åkerström

Discussion

Member takes

Overview

May warrant caution relying on imaging alone for subtyping; leaves open validation of steroidomics and functional imaging in prospective studies.

Key Points

To address the challenge of subtype differentiation in primary aldosteronism for improved management and treatment.
Reviewed current approaches to subtype differentiation in primary aldosteronism.
Discussed limitations of adrenal imaging and clinical variables for accurate diagnostics.
Evaluated the gold standard of adrenal vein sampling and its complexities.
Summarized emerging diagnostic techniques like positron emission tomography, steroidomics, proteomics, and transcriptomics.
Current diagnostic methods misclassify over one third of primary aldosteronism cases.
Adrenal vein sampling remains the gold standard but is technically challenging and limited to specialized centers.
Developments in steroidomics and proteomics show promise for enhancing subtype differentiation in primary aldosteronism.

Structured PICO

Population

Patients with primary aldosteronism (PA)

Intervention

Novel diagnostic techniques including positron emission tomography (PET), steroidomics, proteomics, transcriptomics, and HISTALDO histopathological assessment

Comparator

Conventional diagnostic approaches including adrenal vein sampling (AVS) and standard adrenal imaging (CT/MRI)

Outcome

Accuracy of subtype differentiation (unilateral vs. bilateral disease)

Novel diagnostic techniques, including functional PET imaging and standardized histopathology (HISTALDO), offer improved accuracy for subtype differentiation in primary aldosteronism compared to traditional methods.

Cite This Study

Ragnarsson et al. (2025) studied this question. Adrenal imaging misclassifies over one third of patients with primary aldosteronism, highlighting the need for more accurate diagnostic techniques for subtype differentiation.

synapsesocial.com/papers/6963220c91e05aa366cb879d https://doi.org/10.1111/joim.70055

View Full Paper

Ask AI

Bookmark

January 10, 2026Journal of Internal MedicineOpen Access

Standard adrenal imaging misclassifies ~33% of primary aldosteronism patients, driving the need for novel diagnostics.

View Full Paper

Ask AI

Bookmark

Why the study?

Current subtype differentiation in primary aldosteronism via CT, MRI, and adrenal vein sampling has major limitations, creating a need for more accurate diagnostic approaches.

Design

Review

Key result

Adrenal imaging misclassifies over one third of patients with primary aldosteronism, highlighting the need for more accurate diagnostic techniques for subtype differentiation.

Authors

ÓRÓskar Ragnarsson CJC. Christofer Juhlin TÅTobias Åkerström

Discussion

Member takes

Overview

May warrant caution relying on imaging alone for subtyping; leaves open validation of steroidomics and functional imaging in prospective studies.

Key Points

To address the challenge of subtype differentiation in primary aldosteronism for improved management and treatment.
Reviewed current approaches to subtype differentiation in primary aldosteronism.
Discussed limitations of adrenal imaging and clinical variables for accurate diagnostics.
Evaluated the gold standard of adrenal vein sampling and its complexities.
Summarized emerging diagnostic techniques like positron emission tomography, steroidomics, proteomics, and transcriptomics.
Current diagnostic methods misclassify over one third of primary aldosteronism cases.
Adrenal vein sampling remains the gold standard but is technically challenging and limited to specialized centers.
Developments in steroidomics and proteomics show promise for enhancing subtype differentiation in primary aldosteronism.

Structured PICO

Population

Patients with primary aldosteronism (PA)

Intervention

Novel diagnostic techniques including positron emission tomography (PET), steroidomics, proteomics, transcriptomics, and HISTALDO histopathological assessment

Comparator

Conventional diagnostic approaches including adrenal vein sampling (AVS) and standard adrenal imaging (CT/MRI)

Outcome

Accuracy of subtype differentiation (unilateral vs. bilateral disease)

Cite This Study

synapsesocial.com/papers/6963220c91e05aa366cb879d https://doi.org/10.1111/joim.70055

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark